Cetilistat (ATL-962) is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
Molecular Weight:
401.58
Purity:
97.12%
CAS Number:
[282526-98-1]
Formula:
C25H39NO3
Target:
Lipase|||Others|||Lipid
T3283
* VAT and and shipping costs not included. Errors and price changes excepted